| # | Drug | Count |
|---|---|---|
| 0 | PANCRELIPASE | 469 |
| 1 | ADALIMUMAB | 314 |
| 2 | VENETOCLAX | 217 |
| 3 | IBRUTINIB | 107 |
| 4 | DENOSUMAB | 103 |
| 5 | ABIRATERONE ACETATE | 97 |
| 6 | PEGFILGRASTIM | 88 |
| 7 | AMBRISENTAN | 75 |
| 8 | UPADACITINIB | 73 |
| 9 | ETANERCEPT | 70 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FERRIC SUBSULFATE | 1 | 0.0385 |
| 1 | ASCORBIC ACID, TOCOPHERYL ACID SUCCINATE, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE, FOLIC ACID, COBALAMIN, BIOTIN, PANTOTHENIC ACID, ZINC, SELENIUM | 1 | 0.0185 |
| 2 | REVUMENIB | 19 | 0.0184 |
| 3 | ALUMINUM SULFATE TETRADECAHYDRATE, CALCIUM ACETATE MONOHYDRATE | 1 | 0.0169 |
| 4 | PANCRELIPASE | 469 | 0.0118 |
| 5 | QUIZARTINIB | 6 | 0.0085 |
| 6 | PONATINIB HYDROCHLORIDE | 41 | 0.0078 |
| 7 | PEGFILGRASTIM | 88 | 0.0073 |
| 8 | OLUTASIDENIB | 2 | 0.0069 |
| 9 | DOXERCALCIFEROL | 1 | 0.0060 |
| # | Drug class | Count |
|---|---|---|
| 0 | BCL-2 Inhibitor [EPC] | 217 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 203 |
| 2 | Interleukin-23 Antagonist [EPC] | 198 |
| 3 | Kinase Inhibitor [EPC] | 167 |
| 4 | Leukocyte Growth Factor [EPC] | 147 |
| 5 | Corticosteroid [EPC] | 146 |
| 6 | Endothelin Receptor Antagonist [EPC] | 142 |
| 7 | RANK Ligand Inhibitor [EPC] | 103 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 99 |
| 9 | Alkylating Drug [EPC] | 86 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 14 | 0.0203 |
| 1 | BCL-2 Inhibitor [EPC] | 217 | 0.0035 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 5 | 0.0024 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 21 | 0.0024 |
| 4 | Complement 5a Receptor Antagonist [EPC] | 14 | 0.0021 |
| 5 | Interleukin-23 Antagonist [EPC] | 198 | 0.0019 |
| 6 | Provitamin D2 Compound [EPC] | 55 | 0.0018 |
| 7 | Glucosylceramide Synthase Inhibitor [EPC] | 5 | 0.0018 |
| 8 | Endoglycosidase [EPC] | 3 | 0.0016 |
| 9 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 5 | 0.0015 |